A Review on Prevalence, economic and Safety about over the counter drugs (OTC)

Abstract

This review article focuses on two main topics: the use and impact of over-the-counter (OTC) medications, and the management of osteoarthritis (OA). For OTC medications, the article highlights their increasing prevalence and economic significance from 2020 to 2023. The prevalence of OTC medication usage rose significantly from 37.7% in 2020 to 85.4% in 2023, with a similar upward trend in economic impact, reaching 79.6% in 2023. The safety of these medications is compared with other agents, particularly multivitamins, which are deemed safer and more effective. The article examines a variety of OTC medications including those for colds, allergies, digestive issues, pain, and more, concluding that in 2023, OTC medications are not only more commonly used but also carry significant economic weight. It critically reviews various treatment options, advocating for a multidisciplinary and multimodal approach. This includes patient education, pharmaceuticals, alternative medicine, surgery, and physical therapy, among others. The article emphasizes the importance of early diagnosis, prevention, and a tailored treatment plan. It advocates for healthcare professionals to have a comprehensive understanding of OA management, stressing the importance of combining different therapies for optimal patient outcomes.